Image of hexagons and lines

DC Discussion Group

Home / Meetings and Events / Event

April 30, 2024

Rockville, MD, United States

Contact: Mikaela Sanford
Phone: 510-428-0740

Host Cell Proteins (HCPs) – Risk-based Control Strategies for Established and Novel Therapeutic Biological Products 

Institute for Bioscience and Biotechnology Research

9600 Gudelsky Dr.
Rockville, MD, USA

Join us in person at the IBBR campus where you can network with DC-area CASSS members. The April Discussion Group will be fully in-person. This DCDG session will discuss best practices to control HCPs for established recombinant protein products and challenges associated with HCP measurements for emerging cell and gene therapy products. In particular, we will discuss how to apply a risk-based approach and leverage prior knowledge to assure product quality and to meet regulatory expectations.

For more information, visit Discussion Groups